Novavax NVAX
NASDAQ NVAX
$10.46 -0.14 (-1.32%)
At close: Oct 2, 2026 · 4:00 PM EDT

Novavax (NVAX) Gains from Sales and Divestitures (2010 - 2019)

Updated

Novavax (NVAX) posted Gains from Sales and Divestitures of $51.95 million for FY2024.

Analysis

Novavax (NVAX) Gains from Sales and Divestitures (2010 - 2019) Analysis & Trends

Since FY2009, Novavax has reported Gains from Sales and Divestitures for 10 years.

  • Annual Gains from Sales and Divestitures shows a five-year compound annual growth rate of 41.9% (FY2019 to FY2024).
  • The FY2024 figure stands as the highest annual Gains from Sales and Divestitures in data going back to FY2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Novavax 1.72 Bn -1.28 Bn 42.45 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 9.02 Mn
Mar 31, 2019 -88,000.00
Dec 31, 2018 -55,000.00
Jun 30, 2018 -2,000.00
Mar 31, 2018 47,000.00
Dec 31, 2017 25,000.00
Sep 30, 2017 2,000.00
Jun 30, 2017 -231,000.00
Mar 31, 2017 -65,000.00
Dec 31, 2016 -374,000.00
Mar 31, 2014 -3,000.00
Dec 31, 2013 -5,000.00
Sep 30, 2013 -6,000.00
Jun 30, 2013 26,000.00
Mar 31, 2013 17,000.00
Dec 31, 2012 2,000.00
Sep 30, 2012 7,000.00
Dec 31, 2010 -3,000.00
API Access

Novavax Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=NVAX&period=max&api_key=YOUR_API_KEY